(Total Views: 593)
Posted On: 12/14/2023 4:39:56 PM
Post# of 156153
Dr Jay priorities.
January revised protocol. Trial started short term. Clinical Data published. CD07 data urgent publication for cancer. Partnership still open to Dr Jay. 2-6 months hopefully. Not committing to anything but it’s a high priority to get a good partnership.
January revised protocol. Trial started short term. Clinical Data published. CD07 data urgent publication for cancer. Partnership still open to Dr Jay. 2-6 months hopefully. Not committing to anything but it’s a high priority to get a good partnership.


Daniel Rizzo
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com